Literature DB >> 1918001

Immobilized insulin for high capacity affinity chromatography of insulin receptors.

J Markussen1, J Halstrøm, F C Wiberg, L Schäffer.   

Abstract

Insulin receptors can be purified by affinity chromatography on immobilized insulin, but published methods all suffer from a rather low capacity of the affinity columns. By using insulin that has been protected in positions A1 and B29, we have been able to couple the insulin selectively through the B1 amino group to divinyl sulfone-activated agarose. The N terminus of the B-chain is the most innocuous site as far as receptor-insulin interaction is concerned, and this strategy allowed us to make affinity columns with capacities of several milligrams of receptor/ml of resin. The receptor used was the soluble ectodomain of the human insulin receptor, produced in transfected baby hamster kidney cells. The column preparation and the elution conditions are described in detail, as the efficacy of the purification depends strongly on both. The purity of the eluted receptors was so high that quantitative amino acid analysis fitted with theory. The molar absorption coefficient at 278.5 nm was 296,000 M-1 cm-1. Finally, it could be unequivocally established that the soluble receptor binds two molecules of insulin with equal affinity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1918001

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  High affinity binding sites for proinsulin in human IM-9 lymphoblasts.

Authors:  P M Jehle; M P Lutz; R D Fussgaenger
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

2.  Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs.

Authors:  J Markussen; S Havelund; P Kurtzhals; A S Andersen; J Halstrøm; E Hasselager; U D Larsen; U Ribel; L Schäffer; K Vad; I Jonassen
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

3.  Synthesis, characterization and in vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels.

Authors:  Anthony D Tuesca; Collin Reiff; Jeffrey I Joseph; Anthony M Lowman
Journal:  Pharm Res       Date:  2009-01-15       Impact factor: 4.200

4.  Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo.

Authors:  P Kurtzhals; S Havelund; I Jonassen; B Kiehr; U D Larsen; U Ribel; J Markussen
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

5.  A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor.

Authors:  C Kristensen; A S Andersen; M Hach; F C Wiberg; L Schäffer; T Kjeldsen
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

Review 6.  The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling.

Authors:  P De Meyts
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

7.  How insulin engages its primary binding site on the insulin receptor.

Authors:  John G Menting; Jonathan Whittaker; Mai B Margetts; Linda J Whittaker; Geoffrey K-W Kong; Brian J Smith; Christopher J Watson; Lenka Záková; Emília Kletvíková; Jiří Jiráček; Shu Jin Chan; Donald F Steiner; Guy G Dodson; Andrzej M Brzozowski; Michael A Weiss; Colin W Ward; Michael C Lawrence
Journal:  Nature       Date:  2013-01-10       Impact factor: 49.962

8.  Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis.

Authors:  Giovanna Scapin; Venkata P Dandey; Zhening Zhang; Winifred Prosise; Alan Hruza; Theresa Kelly; Todd Mayhood; Corey Strickland; Clinton S Potter; Bridget Carragher
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

9.  How IGF-II Binds to the Human Type 1 Insulin-like Growth Factor Receptor.

Authors:  Yibin Xu; Nicholas S Kirk; Hariprasad Venugopal; Mai B Margetts; Tristan I Croll; Jarrod J Sandow; Andrew I Webb; Carlie A Delaine; Briony E Forbes; Michael C Lawrence
Journal:  Structure       Date:  2020-05-26       Impact factor: 5.006

10.  How ligand binds to the type 1 insulin-like growth factor receptor.

Authors:  Yibin Xu; Geoffrey K-W Kong; John G Menting; Mai B Margetts; Carlie A Delaine; Lauren M Jenkin; Vladislav V Kiselyov; Pierre De Meyts; Briony E Forbes; Michael C Lawrence
Journal:  Nat Commun       Date:  2018-02-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.